Utilisation of novel anti-platelet agents: evidence, guidelines and proven patients' value. | Thromb Haemost;112(1): 12-4, 2014 Jul 03. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Utilisation of novel anti-platelet agents: evidence, guidelines and proven patients' value.

Wallentin, L; Himmelmann, A; Storey, R F; Steg, P G; Harrington, R A.

Affiliation

Wallentin L; Prof. Lars Wallentin, MD, Uppsala University, Uppsala Clinical Research Centre and Department of Medical Sciences, Cardiology, Uppsala, Uppland, Sweden, E-mail: Lars.Wallentin@ucr.uu.se.

Thromb Haemost ; 112(1): 12-4, 2014 Jul 03.

Article in En | MEDLINE | ID: mdl-24816949

Subject(s)

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Piperazines / Thiophenes / Ticlopidine / Platelet Aggregation Inhibitors / Adenosine / Acute Coronary Syndrome Type of study: Guideline / Health_economic_evaluation / Systematic_reviews Limits: Humans Language: En Journal: Thromb Haemost Year: 2014 Document type: Article

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Piperazines / Thiophenes / Ticlopidine / Platelet Aggregation Inhibitors / Adenosine / Acute Coronary Syndrome Type of study: Guideline / Health_economic_evaluation / Systematic_reviews Limits: Humans Language: En Journal: Thromb Haemost Year: 2014 Document type: Article